MT Design
"MT Design" is a figurative mark owned by Midatech Limited, filed at the CIPO on September 8, 2015. It is registered and covers classes 1, 5, 40 and 42.
- Status
- Registered
- Since June 18, 2019
- Filed
- September 8, 2015
- Registered
- June 18, 2019
- Expires
- June 18, 2029
- Application no.
- 1745009
- Registration no.
- TMA1027189
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Figurative mark
- 4 classes
Who owns MT Design
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Midatech Limited
United Kingdom
Representative
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
What the mark covers
The products and services MT Design is filed for, grouped by Nice class.
Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines; nano-particle chemical ingredients for use in pharmaceuticals, medicines and cosmetics; nano-particle ingredients for use in pharmaceuticals and medicines for the treatment of viral diseases and disorders, namely, the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses and spongiform encephalopathies, metabolic diseases and disorders, namely, diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis and muscular dystrophy, diseases and disorders related to the musculoskeletal system, namely, connective tissue diseases, back pain, fractures, sprains and cartilage injuries, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases, neurological diseases and disorders, namely, Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, dermatological diseases and disorders, namely, dermatitis, eczema, psoriasis, skin pigmentation diseases and sexually transmitted diseases, psychiatric diseases and disorders, namely, mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely, autoimmune diseases and immunologic deficiency syndromes, central nervous system diseases and disorders, namely, brain, movement, ocular motility and spinal cord diseases, endocrine diseases and disorders, namely, growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause and obesity, and hormonal diseases and disorders, namely, growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders and sleep disorders; nano-particle ingredients for use in hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; nano-particle ingredients for use in pharmaceuticals and medicines for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; nano-particle ingredients for use in human vaccines
Pharmaceuticals and medicines containing nano-particles for the treatment of viral diseases and disorders, namely the common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, diseases and disorders related to the musculoskeletal system, namely connective tissue diseases, back pain, fractures, sprains, and cartilage injuries, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, dermatological diseases and disorders, namely dermatitis, eczema, psoriasis, skin pigmentation diseases, and sexually transmitted diseases, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes, central nervous system diseases and disorders, namely brain, movement, ocular motility, and spinal cord diseases, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, and hormonal diseases and disorders, namely growth disorders, sexual dysfunction disorders, reproductive disorders, mood disorders, sleep disorders, and metabolic disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of hormonal diseases and disorders, namely hormone replacement therapy preparations, pancreas hormone preparations, thyroid and para-thyroid hormone preparations, adrenal hormone preparations, and pituitary hormone preparations; pharmaceutical products and preparations and medicines containing nano-particles for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, and gastrointestinal related diseases and disorders; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles
Custom manufacture of nano-particles in the field of nano-particle technology for use in medicine, pharmaceuticals, nano-medicine and cosmetics; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of electronic nano-particle devices, namely computers, laboratory analyzers, probes, spectroscopic devices, microfluidic devices, microarray devices, and assays for the sampling, collection, analysis and testing of nano-particles; custom manufacture of medical nano-particle devices, namely medical diagnostic kits, medical sample preparation devices, spectroscopic devices, microfluidic devices, microarray devices, and assays for the sampling, collection, analysis and testing of nano-particles
Scientific research services in the field of nano-particle technology for use in medicine, pharmaceuticals, nano-medicine and cosmetics; pharmaceutical and drug development and discovery services; testing, efficiency and advisory services in the field of nano-particles for use in medicine, pharmaceuticals, nano-medicine and cosmetics; testing, efficiency and technical and scientific advisory services in the field of pharmaceuticals; nano-particle laboratory services
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Extension of Time; Online Request Date: 2019/02/01
- Extension of Time; Online Request Date: 2018/09/05
- Allowance Notice Sent
- Allowed
- Advertised; Vol.64 Issue 3279
- Approved; APPROVED BY PROGRAM EX200M1
- Approval Notice Sent
- Correspondence Created
- Examiner's First Report
4 earlier steps on the official record.
About MT Design
Who owns the trademark "MT Design"?
The CIPO trademark "MT Design" (application 1745009) is owned by Midatech Limited.
What is the status of "MT Design"?
Its status at the CIPO is: registered.
When was "MT Design" registered?
It was registered on June 18, 2019 and is due to expire on June 18, 2029.
Get this data via the API
Everything on this page comes from the Signa API. Pull MT Design and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb4b-93d4-7214-b067-80e679999005
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb4b-93d4-7214-b067-80e679999005",
"object": "trademark",
"mark_text": "MT Design",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1745009",
"filing_date": "2015-09-08",
"nice_classes": [
1,
5,
40,
42
],
"owners": [
{
"name": "MIDATECH LIMITED",
"entity_id": "ent_019ebaf3-9aef-735b-a6dd-65e4baf52602"
}
]
}